NO992676L - 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse - Google Patents

1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse

Info

Publication number
NO992676L
NO992676L NO992676A NO992676A NO992676L NO 992676 L NO992676 L NO 992676L NO 992676 A NO992676 A NO 992676A NO 992676 A NO992676 A NO 992676A NO 992676 L NO992676 L NO 992676L
Authority
NO
Norway
Prior art keywords
diazabicyclo
oct
preparation
therapeutic use
ylmethyl
Prior art date
Application number
NO992676A
Other languages
English (en)
Norwegian (no)
Other versions
NO992676D0 (no
Inventor
Alistair Lochead
Samir Jegham
Alain Nedelec
Axelle Solignac
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO992676D0 publication Critical patent/NO992676D0/no
Publication of NO992676L publication Critical patent/NO992676L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO992676A 1996-12-04 1999-06-02 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse NO992676L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614847A FR2756563B1 (fr) 1996-12-04 1996-12-04 Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
PCT/FR1997/002174 WO1998024790A1 (fr) 1996-12-04 1997-12-02 Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-ylmethyle, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
NO992676D0 NO992676D0 (no) 1999-06-02
NO992676L true NO992676L (no) 1999-07-29

Family

ID=9498306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992676A NO992676L (no) 1996-12-04 1999-06-02 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse

Country Status (19)

Country Link
US (1) US6057321A (cs)
EP (1) EP0942910A1 (cs)
JP (1) JP2001504855A (cs)
KR (1) KR20000069283A (cs)
CN (1) CN1239962A (cs)
AU (1) AU7624598A (cs)
BG (1) BG103432A (cs)
BR (1) BR9714215A (cs)
CA (1) CA2271072A1 (cs)
CZ (1) CZ193799A3 (cs)
EE (1) EE9900218A (cs)
FR (1) FR2756563B1 (cs)
HU (1) HUP9904206A3 (cs)
IL (1) IL129927A0 (cs)
NO (1) NO992676L (cs)
NZ (1) NZ336044A (cs)
SK (1) SK74199A3 (cs)
TR (1) TR199901068T2 (cs)
WO (1) WO1998024790A1 (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2223588C (en) 1995-06-07 2004-01-06 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
WO2004090030A1 (en) * 2003-04-08 2004-10-21 Ciba Specialty Chemicals Holding Inc. Light stabilising polymer dispersants in pigment dispersions
US7880683B2 (en) * 2004-08-18 2011-02-01 Ruckus Wireless, Inc. Antennas with polarization diversity
US8198386B2 (en) 2007-04-16 2012-06-12 Daikin Industries, Ltd. Fluorine-containing elastomer composition and sealing material made of same
CN101842375A (zh) * 2007-09-03 2010-09-22 巴斯夫欧洲公司 制备teda衍生物的方法
CN102046629A (zh) * 2008-05-30 2011-05-04 东曹株式会社 羟基烷基三亚乙基二胺类化合物的制造方法以及使用该化合物的用于制造聚氨酯树脂的催化剂组合物
US20110077376A1 (en) * 2008-05-30 2011-03-31 Katsumi Tokumoto Process for producing hydroxyalkyltriethylenediamine, and catalyst composition for the production of polyurethane resin using it
CN101671336B (zh) * 2009-09-23 2013-11-13 辽宁利锋科技开发有限公司 芳杂环并嘧啶衍生物和类似物及其制备方法和用途
JP5504835B2 (ja) * 2009-11-13 2014-05-28 東ソー株式会社 ヒドロキシアルキルピペラジン類及び／又はヒドロキシメチルトリエチレンジアミン類の製造方法
JP5549847B2 (ja) * 2009-11-16 2014-07-16 東ソー株式会社 Ｎ−（２−アルコキシメチル）トリエチレンジアミン類の製造法
JP5707912B2 (ja) * 2010-12-08 2015-04-30 東ソー株式会社 Ｎ−（ジヒドロキシアルキル）ジエチレントリアミン類の組成物、及びそれを用いた２−ヒドロキシ（アルキル）トリエチレンジアミン類の製造方
JP6393959B2 (ja) 2012-05-31 2018-09-26 東ソー株式会社 ポリウレタン樹脂製造用触媒組成物及びそれを用いたポリウレタン樹脂の製造方法
JP6252152B2 (ja) * 2013-12-11 2017-12-27 東ソー株式会社 二環式アミン化合物の製造方法
KR20220055152A (ko) 2020-10-26 2022-05-03 인하대학교 산학협력단 급성 융모양막염 진단용 조성물 및 이를 이용한 급성 융모양막염 진단방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
TW282460B (cs) * 1993-12-28 1996-08-01 Yamanouchi Pharma Co Ltd
FR2735475B1 (fr) * 1995-06-13 1997-07-11 Synthelabo Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
CZ193799A3 (cs) 1999-09-15
FR2756563A1 (fr) 1998-06-05
SK74199A3 (en) 2000-02-14
EP0942910A1 (fr) 1999-09-22
TR199901068T2 (xx) 1999-07-21
HUP9904206A2 (hu) 2000-06-28
EE9900218A (et) 1999-12-15
HUP9904206A3 (en) 2000-07-28
CN1239962A (zh) 1999-12-29
KR20000069283A (ko) 2000-11-25
US6057321A (en) 2000-05-02
NO992676D0 (no) 1999-06-02
BG103432A (en) 2000-06-30
CA2271072A1 (fr) 1998-06-11
JP2001504855A (ja) 2001-04-10
BR9714215A (pt) 2000-04-18
NZ336044A (en) 2000-03-27
AU7624598A (en) 1998-06-29
WO1998024790A1 (fr) 1998-06-11
FR2756563B1 (fr) 1998-12-24
IL129927A0 (en) 2000-02-29

Similar Documents

Publication Publication Date Title
NO992676L (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
DK0870768T3 (da) Azaindol-ethylaminderivater som nikotinacetylcholinreceptor-bindingsmidler
NO960365L (no) Perhydroisoindolderivater som substans-P-antagonister
CA2036618A1 (en) Fused thiophene derivatives, their production and use
PE20020506A1 (es) Derivados de pirazol fusionados como inhibidores de la proteina cinasa
BR0111538A (pt) Derivados de 1,3,8-triaza-espiro 4,5!decan-4-ona como antogonistas de receptor de neurocinina
TR200101155T2 (tr) 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
YU157191A (sh) Antagonisti receptora fibrinogena
DK0958296T3 (da) Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
ATE235476T1 (de) Thiazolidindione derivate, ihre herstellung und verwendung
TR200100698T2 (tr) 5-HT4 alıcı-Antagonistleri olarak Dihidrobenzodioksin Karboksamit ve Keton türevleri
DE69017593D1 (de) Substituierte N-(Imidazolyl)alkyl-alanin-Derivate.
BG94282A (bg) 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они
HUP9700595A1 (hu) Fluor-alkil- és fluor-alkoxicsoporttal helyettesített heterociklikus bradikinin-antagonisták, eljárás ezek előállítására, valamint ezek alkalmazása
EA200200729A1 (ru) Производные 4-фенил-1-пиперазинила, -пиперидинила и -тетрагидропиридила
AP9801410A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists.
HUP0003962A2 (hu) Kinuklidinil-származékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények, e vegyületek alkalmazása, valamint intermedierjeik
ES2102295A1 (es) Nuevos compuestos derivados de la n-benzoilmetil-piperidina.
DK1347960T3 (da) Fremgangsmåde til fremstilling af (+/-) trans-4-p-fluorphenyl-3-hydromethyl-1-methylpiperidin
FI955604A0 (fi) 3-(indol-3-yyli)propenoiinihappojohdannaiset NMDA-antagonisteina
HUP0104045A2 (hu) Eljárás 4-[(2',5'-diamino-6'-halogén-pirimidin-4'-il)-amino]-ciklopent-2-enilmetanol-származékok előállítására
DK0765322T3 (da) Indolderivater som pro-drugs for 5-HT1-lignende receptoragonister
DE69501810D1 (de) Verwendung von 5-Thia-1,4-Diazabicyclo [4.2.0] Octane-3,8-dioxo Verbindungen in der Antitumor-Therapie
ES2127699A1 (es) Nuevos derivados de 2,3-benzodiazepina.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application